FR2071223A5 - Contact lens - for medicament application - Google Patents

Contact lens - for medicament application

Info

Publication number
FR2071223A5
FR2071223A5 FR6944385A FR6944385A FR2071223A5 FR 2071223 A5 FR2071223 A5 FR 2071223A5 FR 6944385 A FR6944385 A FR 6944385A FR 6944385 A FR6944385 A FR 6944385A FR 2071223 A5 FR2071223 A5 FR 2071223A5
Authority
FR
France
Prior art keywords
lens
medicament
contact lens
eye
channel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR6944385A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR6944385A priority Critical patent/FR2071223A5/en
Application granted granted Critical
Publication of FR2071223A5 publication Critical patent/FR2071223A5/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

Transparent protective device for the eye is provided in the form of a contact lens with a h older for th progressive distribution of a medicament or drug which is intended to be absorbed by the eye fluid. The lens, preferably of the corneal type, is made of a soft, transparent plastic material, such as P.V.C. It includes an applicator in the form of an annular cavity on the inside of the body of the lens and extending around the latter. It forms a kind of channel with an outlet along its summit and holds the medicament. The latter may be a liquid, a paste or a powder. Protuberances are provided below the channel to allow the eye fluid to collect and mix progressively with the medicament so that it can circulate freely behind the lens. Increased efficiency is obtained in obtaining the desired therapeutic and analgesic effects. The lens is cheap and can be thrown away after a short period of use.
FR6944385A 1969-12-28 1969-12-28 Contact lens - for medicament application Expired FR2071223A5 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR6944385A FR2071223A5 (en) 1969-12-28 1969-12-28 Contact lens - for medicament application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR6944385A FR2071223A5 (en) 1969-12-28 1969-12-28 Contact lens - for medicament application

Publications (1)

Publication Number Publication Date
FR2071223A5 true FR2071223A5 (en) 1971-09-17

Family

ID=9044953

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6944385A Expired FR2071223A5 (en) 1969-12-28 1969-12-28 Contact lens - for medicament application

Country Status (1)

Country Link
FR (1) FR2071223A5 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1420716A1 (en) * 2001-08-29 2004-05-26 Ricardo A. P. De Carvalho An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues
EP1462095A1 (en) * 2003-03-28 2004-09-29 Robert Steven Davidson Method and apparatus for minimising heat, moisture and shear damage to drugs and other compositions
EP2019646A2 (en) * 2006-05-04 2009-02-04 Herbert Kaufman Method, device, and system for delivery of therapeutic agents to the eye
US8999372B2 (en) 2002-11-14 2015-04-07 Cure Pharmaceutical Corporation Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use
US9561182B2 (en) 2003-08-22 2017-02-07 Cure Pharmaceutical Corporation Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals
US10398644B2 (en) 2002-11-14 2019-09-03 Cure Pharmaceutical Corporation Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1420716A1 (en) * 2001-08-29 2004-05-26 Ricardo A. P. De Carvalho An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues
EP1420716A4 (en) * 2001-08-29 2010-10-27 Carvalho Ricardo A P De An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues
US8999372B2 (en) 2002-11-14 2015-04-07 Cure Pharmaceutical Corporation Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use
US10398644B2 (en) 2002-11-14 2019-09-03 Cure Pharmaceutical Corporation Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
EP1462095A1 (en) * 2003-03-28 2004-09-29 Robert Steven Davidson Method and apparatus for minimising heat, moisture and shear damage to drugs and other compositions
US8840919B2 (en) 2003-03-28 2014-09-23 Cure Pharmaceutical Corporation Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
US9155698B2 (en) 2003-03-28 2015-10-13 Cure Pharmaceutical Corporation Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
US9561182B2 (en) 2003-08-22 2017-02-07 Cure Pharmaceutical Corporation Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals
EP2019646A2 (en) * 2006-05-04 2009-02-04 Herbert Kaufman Method, device, and system for delivery of therapeutic agents to the eye
EP2019646A4 (en) * 2006-05-04 2013-12-04 Herbert Kaufman Method, device, and system for delivery of therapeutic agents to the eye

Similar Documents

Publication Publication Date Title
US3598122A (en) Bandage for administering drugs
ES418117A1 (en) Medicament inhalation device with audible indicating means
IT1119327B (en) IMPLANTABLE INFUSION DEVICE IN THE BODY OF THE PATIENT
ES437467A1 (en) Drip irrigation device
CA978171A (en) Device for adjusting the amount of flow in a flexible tube, particularly for infusion and transfusion apparatus
FR2071223A5 (en) Contact lens - for medicament application
GB925580A (en) Improvements in and relating to medicated pad or bandage and method of making the same
IL40223A (en) A bioerodible ocular device for the controlled continuous administration of a predetermined dosage of drug to the eye
ES185549U (en) Container for the reception of liquid medical preparations. (Machine-translation by Google Translate, not legally binding)
FR2064794A5 (en) Method and device for the administration of medicaments by inhalation
FR2210910A5 (en) Dispenser for two part liquid compns - with one liquid contained in tube applicable to mouth of second liquid dispenser
FR1464134A (en) Sealing ring in particular for beverage dispensing apparatus as well as apparatus provided with said ring
CN203677370U (en) Treatment eye patch with liquid traditional Chinese medicine
BE781075Q (en) DEVICE INTENDED TO CONTAIN TWO PRODUCTS SEPARATELY AND TO ALLOW THEIR IMMEDIATE MIXING AT THE TIME OF USE
FR2290918A1 (en) Squeeze-bottle dosing device for medicaments - with transparent measuring tube for pasty substances
ES171385U (en) Medical bandage. (Machine-translation by Google Translate, not legally binding)
USD234187S (en) Bottle package
FR2077790A1 (en) Anti-rheumatism medicament - contg butylsalicylamine and ethyl salicylamide
AR192640A1 (en) DEVICE FOR THE DELIVERY OF A PHARMACEUTICAL PRODUCT TO A CAVITY OF THE BODY
GR33093B (en) DEVICE FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES OF WOMEN'S OWN CONTRACTING MEDIA.
Alpert Whither the erotic film?
GB754476A (en) Improved analgesic device
BE769155A (en) Bandage controllably releasing drugs
Bloch et al. The effects of DDD (1, 1-dichloro-2, 2-bis-(p-chlorophenyl) ethane) on the human adrenal; attempts to use an adrenal-destructive agent in the treatment of disseminated mammary and prostatic cancer
Plzak et al. A report on experience with anafranilin therapy in endogenous depressions.

Legal Events

Date Code Title Description
ST Notification of lapse